Biopharma IP theft: Exit interviews to cloud security - Drug Discovery and Development

Retrieved on: 2024-08-20 22:01:24

Tags for this article:

Click the tags to see associated articles and topics

Biopharma IP theft: Exit interviews to cloud security - Drug Discovery and Development. View article details on hiswai:

Excerpt

Biopharma intellectual property theft risks rise with industry churn. A partner at Munger Tolles & Olson offers guidance.

Article found on: www.drugdiscoverytrends.com